Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GMF-H8214 | Human | Biotinylated Human GM-CSF, epitope tag free, ultra sensitivity (primary amine labeling) | ![]() |
![]() ![]() |
|
GMF-H4214 | Human | ActiveMax® Human GM-CSF Protein, Tag Free | ![]() |
![]() ![]() |
Loaded Biotinylated Human GM-CSF, epitope tag free, primary amine labeling (Cat. No. GMF-H8214) on SA Biosensor, can bind Human GM-CSF R alpha, His Tag (SPR verified) (Cat. No. GRA-H52H7) with an affinity constant of 23.1 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Namilumab | AMG-203; Amg-203; IZN-101; MT-203 | Phase Ⅱ | Amgen, Takeda, Izana Bioscience | Ankylosing Spondylitis (AS), Plaque psoriasis, Rheumatoid arthritis (RA) | Details |
Attenuated viral vector immunogene-based therapy and vaccine (Radient Pharmaceuticals) | Phase Ⅰ | Radient, Jaiva Technologies | Cancer | Details | |
Plasmid cDNA vaccine (Colby Pharmaceutical) | Phase Ⅰ | Colby | Prostate cancer | Details | |
GM-CSF cell therapy (University of Wisconsin) | Phase Ⅰ | University of Wisconsin-Madison | Melanoma | Details | |
TJ-003234 | TJ-003234; TJ-003234RAR101; TJM-2,TJ003234,TJM2 | Phase Ⅱ | I-MAB Biopharma | Coronavirus Disease 2019 (COVID-19) | Details |
Lenzilumab | KB-003 | Phase Ⅲ | KaloBios | Coronavirus Disease 2019 (COVID-19) | Details |
Pancreatic cancer immunotherapy (Cell Genesys) | Phase Ⅱ | Cell Genesys | Pancreatic cancer | Details | |
Gimsilumab | MORAb-022 | Phase Ⅱ | Morphotek | Nasopharyngeal cancer | Details |
Otilimab | GSK-3196165; MOR-103; MOR-04357; GSK-165 | Phase Ⅲ | University of Melbourne, GlaxoSmithKline, MorphoSys | Rheumatoid arthritis (RA) | Details |
PBI-1402 | PBI-1402 | Phase Ⅱ | Prometic Life Sciences, Shanghai Allist Pharmaceuticals | Anemia | Details |
PD-360324 | PD-360324; PD-0360324 | Phase Ⅱ | Pfizer | Solid tumours | Details |
This web search service is supported by Google Inc.